Request for Covid-19 Impact Assessment of this Report
China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.
This report studies the Atopic Dermatitis Treatment development status and future trend in China, focuses on top players in China, also splits Atopic Dermatitis Treatment by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.
The major players in China market include
Sanofi
Regeneron Pharmaceuticals
Astellas Pharma
Anacor Pharmaceuticals
Meda AB
GlaxoSmithKline
AstraZeneca
Pfizer
Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Infancy Type
Childhood Type
Youth and Adulthood Type
On the basis of the end users/application, this report covers
Hospital
Clinic
Home
If you have any special requirements, please let us know and we will offer you the report as you want.
China Atopic Dermatitis Treatment Market Research Report 2017
1 Atopic Dermatitis Treatment Overview
1.1 Product Overview and Scope of Atopic Dermatitis Treatment
1.2 Classification of Atopic Dermatitis Treatment by Product Category
1.2.1 China Atopic Dermatitis Treatment Sales (K Units) Comparison by Type (2012-2022)
1.2.2 China Atopic Dermatitis Treatment Sales (K Units) Market Share by Type in 2016
1.2.3 Infancy Type
1.2.4 Childhood Type
1.2.5 Youth and Adulthood Type
1.3 China Atopic Dermatitis Treatment Market by Application/End Users
1.3.1 China Atopic Dermatitis Treatment Sales (K Units) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home
1.4 China Atopic Dermatitis Treatment Market by Region
1.4.1 China Atopic Dermatitis Treatment Market Size (Million USD) Comparison by Region (2012-2022)
1.4.2 South China Atopic Dermatitis Treatment Status and Prospect (2012-2022)
1.4.3 East China Atopic Dermatitis Treatment Status and Prospect (2012-2022)
1.4.4 Southwest China Atopic Dermatitis Treatment Status and Prospect (2012-2022)
1.4.5 Northeast China Atopic Dermatitis Treatment Status and Prospect (2012-2022)
1.4.6 North China Atopic Dermatitis Treatment Status and Prospect (2012-2022)
1.4.7 Central China Atopic Dermatitis Treatment Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Atopic Dermatitis Treatment (2012-2022)
1.5.1 China Atopic Dermatitis Treatment Sales (K Units) and Growth Rate (%)(2012-2022)
1.5.2 China Atopic Dermatitis Treatment Revenue (Million USD) and Growth Rate (%)(2012-2022)
2 China Atopic Dermatitis Treatment Market Competition by Players/Manufacturers
2.1 China Atopic Dermatitis Treatment Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Atopic Dermatitis Treatment Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Atopic Dermatitis Treatment Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.4 China Atopic Dermatitis Treatment Market Competitive Situation and Trends
2.4.1 China Atopic Dermatitis Treatment Market Concentration Rate
2.4.2 China Atopic Dermatitis Treatment Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Atopic Dermatitis Treatment Manufacturing Base Distribution, Sales Area, Product Types
3 China Atopic Dermatitis Treatment Sales and Revenue by Region (2012-2017)
3.1 China Atopic Dermatitis Treatment Sales (K Units) and Market Share by Region (2012-2017)
3.2 China Atopic Dermatitis Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Atopic Dermatitis Treatment Price (USD/Unit) by Regions (2012-2017)
4 China Atopic Dermatitis Treatment Sales and Revenue by Type/ Product Category (2012-2017)
4.1 China Atopic Dermatitis Treatment Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
4.2 China Atopic Dermatitis Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Atopic Dermatitis Treatment Price (USD/Unit) by Type (2012-2017)
4.4 China Atopic Dermatitis Treatment Sales Growth Rate (%) by Type (2012-2017)
5 China Atopic Dermatitis Treatment Sales by Application (2012-2017)
5.1 China Atopic Dermatitis Treatment Sales (K Units) and Market Share by Application (2012-2017)
5.2 China Atopic Dermatitis Treatment Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 China Atopic Dermatitis Treatment Players/Suppliers Profiles and Sales Data
6.1 Sanofi
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Atopic Dermatitis Treatment Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Sanofi Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.1.4 Main Business/Business Overview
6.2 Regeneron Pharmaceuticals
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Atopic Dermatitis Treatment Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Regeneron Pharmaceuticals Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.2.4 Main Business/Business Overview
6.3 Astellas Pharma
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Atopic Dermatitis Treatment Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Astellas Pharma Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.3.4 Main Business/Business Overview
6.4 Anacor Pharmaceuticals
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Atopic Dermatitis Treatment Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Anacor Pharmaceuticals Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.4.4 Main Business/Business Overview
6.5 Meda AB
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Atopic Dermatitis Treatment Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Meda AB Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Atopic Dermatitis Treatment Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 GlaxoSmithKline Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.6.4 Main Business/Business Overview
6.7 AstraZeneca
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Atopic Dermatitis Treatment Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 AstraZeneca Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.7.4 Main Business/Business Overview
6.8 Pfizer
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Atopic Dermatitis Treatment Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Pfizer Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.8.4 Main Business/Business Overview
7 Atopic Dermatitis Treatment Manufacturing Cost Analysis
7.1 Atopic Dermatitis Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Atopic Dermatitis Treatment
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Atopic Dermatitis Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Atopic Dermatitis Treatment Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Atopic Dermatitis Treatment Market Size (Sales and Revenue) Forecast (2017-2022)
11.1 China Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 China Atopic Dermatitis Treatment Sales (K Units) Forecast by Type (2017-2022)
11.3 China Atopic Dermatitis Treatment Sales (K Units) Forecast by Application (2017-2022)
11.4 China Atopic Dermatitis Treatment Sales (K Units) Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Atopic Dermatitis Treatment Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Atopic Dermatitis Treatment Sales (K Units) by Application (2016-2022)
Figure Product Picture of Atopic Dermatitis Treatment
Table China Atopic Dermatitis Treatment Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Atopic Dermatitis Treatment Sales Volume Market Share by Types in 2016
Figure Infancy Type Product Picture
Figure Childhood Type Product Picture
Figure Youth and Adulthood Type Product Picture
Figure China Atopic Dermatitis Treatment Sales (K Units) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Atopic Dermatitis Treatment by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Examples
Table Key Downstream Customer in Home
Figure South China Atopic Dermatitis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Atopic Dermatitis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Atopic Dermatitis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Atopic Dermatitis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Atopic Dermatitis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Atopic Dermatitis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Atopic Dermatitis Treatment Sales (K Units) and Growth Rate (%)(2012-2022)
Figure China Atopic Dermatitis Treatment Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Atopic Dermatitis Treatment Sales of Key Players/Manufacturers (2012-2017)
Table China Atopic Dermatitis Treatment Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Atopic Dermatitis Treatment Sales Share (%) by Players/Manufacturers
Figure 2017 China Atopic Dermatitis Treatment Sales Share (%) by Players/Manufacturers
Table China Atopic Dermatitis Treatment Revenue by Players/Manufacturers (2012-2017)
Table China Atopic Dermatitis Treatment Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Atopic Dermatitis Treatment Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Atopic Dermatitis Treatment Revenue Market Share (%) by Players/Manufacturers
Table China Market Atopic Dermatitis Treatment Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Atopic Dermatitis Treatment Average Price of Key Players/Manufacturers in 2016
Figure China Atopic Dermatitis Treatment Market Share of Top 3 Players/Manufacturers
Figure China Atopic Dermatitis Treatment Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Atopic Dermatitis Treatment Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Atopic Dermatitis Treatment Product Category
Table China Atopic Dermatitis Treatment Sales (K Units) by Regions (2012-2017)
Table China Atopic Dermatitis Treatment Sales Share (%) by Regions (2012-2017)
Figure China Atopic Dermatitis Treatment Sales Share (%) by Regions (2012-2017)
Figure China Atopic Dermatitis Treatment Sales Market Share (%) by Regions in 2016
Table China Atopic Dermatitis Treatment Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Atopic Dermatitis Treatment Revenue Market Share (%) by Regions (2012-2017)
Figure China Atopic Dermatitis Treatment Revenue Market Share (%) by Regions (2012-2017)
Figure China Atopic Dermatitis Treatment Revenue Market Share (%) by Regions in 2016
Table China Atopic Dermatitis Treatment Price (USD/Unit) by Regions (2012-2017)
Table China Atopic Dermatitis Treatment Sales (K Units) by Type (2012-2017)
Table China Atopic Dermatitis Treatment Sales Share (%) by Type (2012-2017)
Figure China Atopic Dermatitis Treatment Sales Share (%) by Type (2012-2017)
Figure China Atopic Dermatitis Treatment Sales Market Share (%) by Type in 2016
Table China Atopic Dermatitis Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Atopic Dermatitis Treatment Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Atopic Dermatitis Treatment by Type (2012-2017)
Figure Revenue Market Share of Atopic Dermatitis Treatment by Type in 2016
Table China Atopic Dermatitis Treatment Price (USD/Unit) by Types (2012-2017)
Figure China Atopic Dermatitis Treatment Sales Growth Rate (%) by Type (2012-2017)
Table China Atopic Dermatitis Treatment Sales (K Units) by Applications (2012-2017)
Table China Atopic Dermatitis Treatment Sales Market Share (%) by Applications (2012-2017)
Figure China Atopic Dermatitis Treatment Sales Market Share (%) by Application (2012-2017)
Figure China Atopic Dermatitis Treatment Sales Market Share (%) by Application in 2016
Table China Atopic Dermatitis Treatment Sales Growth Rate (%) by Application (2012-2017)
Figure China Atopic Dermatitis Treatment Sales Growth Rate (%) by Application (2012-2017)
Table Sanofi Atopic Dermatitis Treatment Basic Information List
Table Sanofi Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Sanofi Atopic Dermatitis Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Sanofi Atopic Dermatitis Treatment Sales Market Share (%) in China (2012-2017)
Figure Sanofi Atopic Dermatitis Treatment Revenue Market Share (%) in China (2012-2017)
Table Regeneron Pharmaceuticals Atopic Dermatitis Treatment Basic Information List
Table Regeneron Pharmaceuticals Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Regeneron Pharmaceuticals Atopic Dermatitis Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Regeneron Pharmaceuticals Atopic Dermatitis Treatment Sales Market Share (%) in China (2012-2017)
Figure Regeneron Pharmaceuticals Atopic Dermatitis Treatment Revenue Market Share (%) in China (2012-2017)
Table Astellas Pharma Atopic Dermatitis Treatment Basic Information List
Table Astellas Pharma Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Astellas Pharma Atopic Dermatitis Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Astellas Pharma Atopic Dermatitis Treatment Sales Market Share (%) in China (2012-2017)
Figure Astellas Pharma Atopic Dermatitis Treatment Revenue Market Share (%) in China (2012-2017)
Table Anacor Pharmaceuticals Atopic Dermatitis Treatment Basic Information List
Table Anacor Pharmaceuticals Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Anacor Pharmaceuticals Atopic Dermatitis Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Anacor Pharmaceuticals Atopic Dermatitis Treatment Sales Market Share (%) in China (2012-2017)
Figure Anacor Pharmaceuticals Atopic Dermatitis Treatment Revenue Market Share (%) in China (2012-2017)
Table Meda AB Atopic Dermatitis Treatment Basic Information List
Table Meda AB Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Meda AB Atopic Dermatitis Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Meda AB Atopic Dermatitis Treatment Sales Market Share (%) in China (2012-2017)
Figure Meda AB Atopic Dermatitis Treatment Revenue Market Share (%) in China (2012-2017)
Table GlaxoSmithKline Atopic Dermatitis Treatment Basic Information List
Table GlaxoSmithKline Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure GlaxoSmithKline Atopic Dermatitis Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline Atopic Dermatitis Treatment Sales Market Share (%) in China (2012-2017)
Figure GlaxoSmithKline Atopic Dermatitis Treatment Revenue Market Share (%) in China (2012-2017)
Table AstraZeneca Atopic Dermatitis Treatment Basic Information List
Table AstraZeneca Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure AstraZeneca Atopic Dermatitis Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure AstraZeneca Atopic Dermatitis Treatment Sales Market Share (%) in China (2012-2017)
Figure AstraZeneca Atopic Dermatitis Treatment Revenue Market Share (%) in China (2012-2017)
Table Pfizer Atopic Dermatitis Treatment Basic Information List
Table Pfizer Atopic Dermatitis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Pfizer Atopic Dermatitis Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Pfizer Atopic Dermatitis Treatment Sales Market Share (%) in China (2012-2017)
Figure Pfizer Atopic Dermatitis Treatment Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Atopic Dermatitis Treatment
Figure Manufacturing Process Analysis of Atopic Dermatitis Treatment
Figure Atopic Dermatitis Treatment Industrial Chain Analysis
Table Raw Materials Sources of Atopic Dermatitis Treatment Major Players/Manufacturers in 2016
Table Major Buyers of Atopic Dermatitis Treatment
Table Distributors/Traders List
Figure China Atopic Dermatitis Treatment Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Atopic Dermatitis Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Atopic Dermatitis Treatment Price (USD/Unit) Trend Forecast (2017-2022)
Table China Atopic Dermatitis Treatment Sales (K Units) Forecast by Type (2017-2022)
Figure China Atopic Dermatitis Treatment Sales (K Units) Forecast by Type (2017-2022)
Figure China Atopic Dermatitis Treatment Sales Volume Market Share Forecast by Type in 2022
Table China Atopic Dermatitis Treatment Sales (K Units) Forecast by Application (2017-2022)
Figure China Atopic Dermatitis Treatment Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Atopic Dermatitis Treatment Sales Volume Market Share Forecast by Application in 2022
Table China Atopic Dermatitis Treatment Sales (K Units) Forecast by Regions (2017-2022)
Table China Atopic Dermatitis Treatment Sales Volume Share Forecast by Regions (2017-2022)
Figure China Atopic Dermatitis Treatment Sales Volume Share Forecast by Regions (2017-2022)
Figure China Atopic Dermatitis Treatment Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...